Canada Life
KURA icon

Canada Life’s Kura Oncology KURA Stock Holding History

Canada Life’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69K Hold
6,268
– – ﹤0.01% 1716
2026
Q1 		$51K Hold
6,268
– – ﹤0.01% 1756
2025
Q4 		$65K Hold
6,268
– – ﹤0.01% 1768
2025
Q3 		$56K Hold
6,268
– – ﹤0.01% 1810
2025
Q2 		$36K Hold
6,268
– – ﹤0.01% 1850
2025
Q1 		$41K Sell
6,268
-11,568
-65% -$90.1K ﹤0.01% 1880
2024
Q4 		$155K Hold
17,836
– – ﹤0.01% 1761
2024
Q3 		$349K Hold
17,836
– – ﹤0.01% 1739
2024
Q2 		$367K Buy
17,836
+11,568
+185% +$238K ﹤0.01% 1743
2024
Q1 		$134K Hold
6,268
– – ﹤0.01% 1887
2023
Q4 		$90K Buy
6,268
+3,402
+119% +$33.5K ﹤0.01% 1967
2023
Q3 		$26K Hold
2,866
– – ﹤0.01% 2099
2023
Q2 		$30K Hold
2,866
– – ﹤0.01% 2078
2023
Q1 		$35K Hold
2,866
– – ﹤0.01% 2118
2022
Q4 		$36K Hold
2,866
– – ﹤0.01% 2143
2022
Q3 		$39K Hold
2,866
– – ﹤0.01% 2142
2022
Q2 		$53K Hold
2,866
– – ﹤0.01% 2052
2022
Q1 		$49K Hold
2,866
– – ﹤0.01% 2161
2021
Q4 		$40K Hold
2,866
– – ﹤0.01% 2230
2021
Q3 		$54K Hold
2,866
– – ﹤0.01% 2215
2021
Q2 		$60K Sell
2,866
-952
-25% -$23.6K ﹤0.01% 2215
2021
Q1 		$107K Hold
3,818
– – ﹤0.01% 2087
2020
Q4 		$124K Hold
3,818
– – ﹤0.01% 2072
2020
Q3 		$117K Hold
3,818
– – ﹤0.01% 2009
2020
Q2 		$62K Buy
3,818
+2,139
+127% +$30.9K ﹤0.01% 2168
2020
Q1 		$17K Hold
1,679
– – ﹤0.01% 2409
2019
Q4 		$23K Buy
+1,679
New +$24.9K ﹤0.01% 2467
2019
Q3 		– Sell
-3,165
Closed -$62K – 1730
2019
Q2 		$62K Sell
3,165
-1,448
-31% -$24K ﹤0.01% 2385
2019
Q1 		$76K Hold
4,613
– – ﹤0.01% 2149
2018
Q4 		$62K Buy
+4,613
New +$61.1K ﹤0.01% 2298

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Canada Life's KURA Position: Q2 2026 in Review

Canada Life held its Kura Oncology (KURA) position steady in Q2 2026 at 6,268 shares worth $69K. The position accounts for ﹤0.01% of the portfolio, ranked #1716.

Canada Life first reported a position in KURA in Q4 2018 and has held it in 30 quarters since. The position peaked at $367K in Q2 2024. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Canada Life held 6,268 shares of Kura Oncology worth $69K as of Q2 2026.
  • Canada Life left its Kura Oncology share count unchanged in Q2 2026.
  • Kura Oncology made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1716 holding.
  • Canada Life first reported a position in Kura Oncology in Q4 2018 and has held it in 30 quarters since.
  • Canada Life's Kura Oncology position peaked at $367K in Q2 2024.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.